Rare diseases
Investigational molecules
Locations
Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment
PolandStudy of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer
PolandStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
PolandStudy of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment
PolandSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
PolandStudy of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer
PolandStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
PolandStudy of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
PolandStudy of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis
PolandStudy of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
PolandStudy of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment
PolandStudy of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
